Mokam Life Science Research Institute Signs MOU for AI-Based Drug Development with Ajou University Medical Center and Quattro Precision Medicine Research Institute

Mokam Life Science Research Institute announced on April 22 that it has signed a memorandum of understanding (MOU) with Ajou University Medical Center and the Quattro Precision Medicine Research Institute at Ajou University for mutual research cooperation in the field of artificial intelligence-based drug development.

After the MOU event, Kim Cheolho, Director of the Quattro Precision Medicine Research Center at Ajou University (left), and Shin Hyunjin, Director of Mokam Life Science Research Institute, are taking a commemorative photo. Mokam Life Science Research Institute

The signing ceremony was held on the afternoon of April 21 at Hongjaegwan, Ajou University, with Shin Hyunjin, Director of Mokam Life Science Research Institute, Kim Cheolho, Director of Quattro Precision Medicine Research Institute, and other related officials in attendance.

Through this agreement, the institutions plan to strengthen their collaboration in AI-based drug development. By combining the clinical data of Ajou University Medical Center and the Quattro Precision Medicine Research Institute with the AI research capabilities of Mokam Life Science Research Institute, they aim to establish a foundation for cooperative drug development.

Mokam Life Science Research Institute intends to expand its academic-industry-institute network by collaborating with clinical and precision medicine research institutions, and to establish a cooperation framework based on joint research and project planning.

Director Shin Hyunjin stated, "This MOU has laid the foundation for multi-institutional research collaboration," and added, "We will continue to communicate closely with our partner organizations to deliver tangible results in the future."

This content was produced with the assistance of AI translation services.